Literature DB >> 27379824

A Subtrochanteric Femoral Stress Fracture following Bisphosphonate Treatment in an Adolescent Girl.

Alison M Boyce1, Michael T Collins, Laura L Tosi, Rachel I Gafni.   

Abstract

Atypical subtrochanteric and diaphyseal femoral fractures (AFFs) have emerged as a potential complication of bisphosphonate treatment in adults. Despite increasing off-label use of bisphosphonates in children and adolescents for a variety of skeletal disorders, there have been no reports of AFFs in children or adolescents outside of the osteogenesis imperfecta population. We present the case of a 16-year-old girl who developed a subtrochanteric femoral stress fracture following pamidronate treatment for idiopathic juvenile osteoporosis.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27379824      PMCID: PMC5218986          DOI: 10.1159/000447425

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  14 in total

1.  Stress fractures of the femoral shaft in athletes: a new treatment algorithm.

Authors:  A Ivkovic; I Bojanic; M Pecina
Journal:  Br J Sports Med       Date:  2006-06       Impact factor: 13.800

2.  Atypical femoral diaphyseal fractures documented by serial DXA.

Authors:  Fergus Eoin McKiernan
Journal:  J Clin Densitom       Date:  2010 Jan-Mar       Impact factor: 2.617

Review 3.  Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.

Authors:  Lydia Gedmintas; Daniel H Solomon; Seoyoung C Kim
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

Review 4.  Stress injury to bone in the female athlete.

Authors:  A Nattiv; T D Armsey
Journal:  Clin Sports Med       Date:  1997-04       Impact factor: 2.182

5.  Unusual Femur Stress Fractures in Children With Osteogenesis Imperfecta and Intramedullary Rods on Long-term Intravenous Pamidronate Therapy.

Authors:  Abdelsalam Hegazy; Mohamed Kenawey; Etienne Sochett; Lianne Tile; Angela M Cheung; Andrew W Howard
Journal:  J Pediatr Orthop       Date:  2016 Oct-Nov       Impact factor: 2.324

6.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

Review 7.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

8.  Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

Authors:  B A Lenart; A S Neviaser; S Lyman; C C Chang; F Edobor-Osula; B Steele; M C H van der Meulen; D G Lorich; J M Lane
Journal:  Osteoporos Int       Date:  2008-12-09       Impact factor: 4.507

9.  Recurrent Proximal Femur Fractures in a Teenager With Osteogenesis Imperfecta on Continuous Bisphosphonate Therapy: Are We Overtreating?

Authors:  Rashida F Vasanwala; Anish Sanghrajka; Nicholas J Bishop; Wolfgang Högler
Journal:  J Bone Miner Res       Date:  2016-03-14       Impact factor: 6.741

Review 10.  Diagnosis, treatment, and rehabilitation of stress fractures in the lower extremity in runners.

Authors:  Leamor Kahanov; Lindsey E Eberman; Kenneth E Games; Mitch Wasik
Journal:  Open Access J Sports Med       Date:  2015-03-27
View more
  3 in total

1.  Bisphosphonate Withdrawal: Effects on Bone Formation and Bone Resorption in Maturing Male Mice.

Authors:  Frank C Ko; Lamya Karim; Daniel J Brooks; Mary L Bouxsein; Marie B Demay
Journal:  J Bone Miner Res       Date:  2017-01-17       Impact factor: 6.741

2.  Intravenous bisphosphonate therapy in children with spinal muscular atrophy.

Authors:  N Nasomyont; L N Hornung; H Wasserman
Journal:  Osteoporos Int       Date:  2019-12-02       Impact factor: 4.507

3.  Bisphosphonate use in children with cerebral palsy.

Authors:  Tim Hurley; Zunera Zareen; Philip Stewart; Ciara McDonnell; Denise McDonald; Eleanor Molloy
Journal:  Cochrane Database Syst Rev       Date:  2021-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.